Nesvacumab clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How each study uses Nesvacumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2011 (1)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Nesvacumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)CompletedPhase 1Regeneron PharmaceuticalsNCT01997164Written as REGN910
- Study of Nesvacumab (REGN910/ SAR307746)CompletedPhase 1Regeneron PharmaceuticalsNCT01271972Written as nesvacumab (REGN910/ SAR307746)
- Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid MalignanciesCompletedPhase 1Regeneron PharmaceuticalsNCT01688960Written as nesvacumab (REGN910/ SAR307746)
Codes
What other systems call Nesvacumab · ClinicalTrials.gg INT018396
- UNII (FDA) WX8293WGLCNESVACUMABConfirmed FDA, Wikidata
- Wikidata Q6998092NesvacumabConfirmed FDA, Wikidata
- NCI Thesaurus C95712NesvacumabOne source FDA
- DrugBank DB15330One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | WX8293WGLC | NESVACUMAB | Confirmed FDA, Wikidata |
| Wikidata | Q6998092 | Nesvacumab | Confirmed FDA, Wikidata |
| NCI Thesaurus | C95712 | Nesvacumab | One source FDA |
| DrugBank | DB15330 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.